Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-23-000020
Filing Date
2023-04-28
Accepted
2023-04-28 13:23:34
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20230331.htm   iXBRL 10-Q 1647391
2 EX-31.1 bmrn-exx311xq12023.htm EX-31.1 9352
3 EX-31.2 bmrn-exx312xq12023.htm EX-31.2 9342
4 EX-32.1 bmrn-exx321xq12023.htm EX-32.1 5237
  Complete submission text file 0001048477-23-000020.txt   7121193

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20230331.xsd EX-101.SCH 44327
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20230331_cal.xml EX-101.CAL 71246
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20230331_def.xml EX-101.DEF 222772
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20230331_lab.xml EX-101.LAB 527074
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20230331_pre.xml EX-101.PRE 348353
62 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20230331_htm.xml XML 1327096
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 23863468
SIC: 2834 Pharmaceutical Preparations